NCT06937177 - Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions

Cancer Weight Loss

Interventions

DRUG

TCMCB07

TCMCB07 is will be provided in single-use vials for subcutaneous administration

DRUG

Placebo

Matching placebo

Trial Locations (17)

27710

NOT_YET_RECRUITING

Investigative Site, Durham

30318

RECRUITING

Investigative Site, Atlanta

33013

RECRUITING

Investigative Site, Hialeah

33063

RECRUITING

Investigative Site, Margate

33140

RECRUITING

Investigative Site, Miami Beach

33321

RECRUITING

Investigative Site, Tamarac

48201

RECRUITING

Investigative Site, Detroit

67214

RECRUITING

Investigative Site, Wichita

68130

RECRUITING

Investigative Site, Omaha

68506

RECRUITING

Investigative Site, Lincoln

73102

RECRUITING

Investigative Site, Oklahoma City

77090

RECRUITING

Investigative Site, Kingwood

78041

RECRUITING

Investigative Site, Laredo

85715

NOT_YET_RECRUITING

Investigative Site, Tucson

90048

NOT_YET_RECRUITING

Investigative Site, Los Angeles

90095

NOT_YET_RECRUITING

Investigative Site, Los Angeles

T6G 1Z2

NOT_YET_RECRUITING

Investigative Site, Edmonton